Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit

Mol Biol Rep. 2019 Jun;46(3):3497-3500. doi: 10.1007/s11033-019-04744-4. Epub 2019 Apr 12.

Abstract

We report a predominance (64.7%) of polyclonal carbapenem-resistant Acinetobacter baumannii (CRAB) strains concurrently producing OXA-23 and OXA-58 carbapenemases in a pediatric intensive care unit in an endemic area. This is the first report of emergence of such double-OXA CRAB strains in a single unit worldwide.

Keywords: Acinetobacter baumannii; Carbapenems; Critical care; Microbial resistance; Pediatrics.

MeSH terms

  • Acinetobacter baumannii / drug effects*
  • Acinetobacter baumannii / metabolism*
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / metabolism
  • Carbapenems / pharmacology*
  • Drug Resistance, Bacterial / immunology
  • Humans
  • Intensive Care Units, Pediatric
  • Microbial Sensitivity Tests
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Carbapenems
  • beta-Lactamases
  • carbapenemase